These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16520409)
1. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Schmidt BM; Sammer U; Fleischmann I; Schlaich M; Delles C; Schmieder RE Hypertension; 2006 Apr; 47(4):650-5. PubMed ID: 16520409 [TBL] [Abstract][Full Text] [Related]
2. Rapid non-genomic effects of aldosterone on the renal vasculature. Schmidt BM Steroids; 2008 Oct; 73(9-10):961-5. PubMed ID: 18242654 [TBL] [Abstract][Full Text] [Related]
3. Rapid nongenomic effects of aldosterone on human forearm vasculature. Schmidt BM; Oehmer S; Delles C; Bratke R; Schneider MP; Klingbeil A; Fleischmann EH; Schmieder RE Hypertension; 2003 Aug; 42(2):156-60. PubMed ID: 12860833 [TBL] [Abstract][Full Text] [Related]
5. Assessment of endothelial function of the renal vasculature in human subjects. Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856 [TBL] [Abstract][Full Text] [Related]
6. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men. Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729 [TBL] [Abstract][Full Text] [Related]
8. Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects. Bech JN; Starklint J; Bentzen H; Nyvad O; Pedersen EB J Card Fail; 2013 Nov; 19(11):776-85. PubMed ID: 24263123 [TBL] [Abstract][Full Text] [Related]
9. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension. Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876 [TBL] [Abstract][Full Text] [Related]
10. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393 [TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753 [TBL] [Abstract][Full Text] [Related]
12. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans. Bech JN; Nielsen CB; Pedersen EB Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847 [TBL] [Abstract][Full Text] [Related]
13. Physiological role of nitric oxide in regulation of renal function in humans. Haynes WG; Hand MF; Dockrell ME; Eadington DW; Lee MR; Hussein Z; Benjamin N; Webb DJ Am J Physiol; 1997 Mar; 272(3 Pt 2):F364-71. PubMed ID: 9087680 [TBL] [Abstract][Full Text] [Related]
14. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494 [TBL] [Abstract][Full Text] [Related]
15. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329 [TBL] [Abstract][Full Text] [Related]
16. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed. Postma CT; Maessen SM; Thien T; Smits P Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011 [TBL] [Abstract][Full Text] [Related]
17. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594 [TBL] [Abstract][Full Text] [Related]
18. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension. Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445 [TBL] [Abstract][Full Text] [Related]
19. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Millar CG; Thiemermann C Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724 [TBL] [Abstract][Full Text] [Related]
20. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins. Schindler C; Leuschner S; Schwanebeck U; Kirch W J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]